Trial Profile
Pharmacodynamics and pharmacokinetics of dasatinib in newly diagnosed patients with chronic phase chronic myeloid leukaemia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Sep 2014
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 02 Sep 2014 New trial record